E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/28/2006 in the Prospect News Biotech Daily.

Alliance facing forced liquidation, unable to repay senior notes

By Lisa Kerner

Charlotte, N.C., Sept. 28 - Alliance Pharmaceutical Corp. said it does not have the means to repay the $11.3 million in principal and accrued interest when its senior notes come due in April 2007. As a result, the note holders may force the company's liquidation, the company warned in a 10-K filing with the Securities and Exchange Commission.

The filing also details Alliance's lack of profitability and the fact the company has no current revenue from product sales. Since its inception, Alliance has had net operating losses, a trend that is expected to continue.

At June 30, the San Diego-based pharmaceutical company had an accumulated deficit of $493.7 million.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.